Rahul Parkih, MD

Senior Physician Advisor for India

Rahul R. Parikh, MD is Professor of Radiation Oncology at the Rutgers Cancer Institute of New Jersey. He serves as the Medical Director of Proton Beam Therapy at the Laurie Proton Therapy Center with Robert Wood Johnson University Hospital in partnership with the Rutgers Cancer Institute of New Jersey. With this position, he has helped to integrate the use of proton therapy into the multidisciplinary oncology treatment programs within the cancer center and across the Robert Wood Johnson Barnabas Health System. Dr. Parikh’s primary research and clinical focus is in pediatric cancers, lymphoma / hematologic malignancies and several disease sites using proton beam therapy (including pediatrics, skull base tumors, brain tumors-benign and malignant). He has a strong research interest in the outcomes of patients treated with advanced radiotherapy modalities. He is also the Fellowship Director for the Precision Radiation Oncology training program, aimed to provide specialty training for international radiation oncology graduates.

In addition to his clinical and academic practice at Rutgers Cancer Institute of New Jersey, he holds several national and international leadership roles within committees in ASTRO (American Society for Therapeutic Radiation Oncology), Steering Committee member of the International Lymphoma Radiation Oncology Group (ILROG), Particle Therapy Co-Operative Group (PTCOG), American Society for Clinical Oncology (ASCO), American Radium Society (ARS), Proton Collaborative Group (PCG), and Children's Oncology Group (COG). He also serves as an active peer reviewer for several oncology-focused journals; he serves on the editorial board for Journal of Clinical Oncology and is an Associate Section Editor for International Journal of Radiation Oncology, Biology, and Physics. He has recently completed his Master of Business Administration (MBA), with a focus in Strategic Leadership, from Rutgers University, School of Business.